<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02843347</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00089102</org_study_id>
    <secondary_id>1U01HL128566</secondary_id>
    <nct_id>NCT02843347</nct_id>
  </id_info>
  <brief_title>STRIDE Biorepository</brief_title>
  <official_title>1503 BMT CTN STRIDE Biorepository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The STRIDE Biorepository is an optional substudy available to participants in &quot;Bone Marrow
      Transplantation vs Standard of Care in Patients with Severe Sickle Cell Disease (BMT CTN
      1503) (STRIDE)&quot;.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A subset of sites for the main study &quot;Bone Marrow Transplantation vs Standard of Care in
      Patients with Severe Sickle Cell Disease (BMT CTN 1503) (STRIDE)&quot; (NCT02766465) will also
      participate in the biorepository portion of the study. The purpose of the biorepository is to
      examine DNA to learn if certain genes predict who will have serious complications of sickle
      cell disease. The STRIDE Biorepository is an optional substudy available to individuals
      enrolled in the main study, who are at a participating site. Participants in the main study
      who consent to take part in the biorepository will have blood drawn at the Baseline Visit.
      This blood will be shipped to Emory University in Atlanta Georgia and stored for future
      research.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2017</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Genetic variants in persons with sickle cell disease</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>A biorepository will be established for future genetic research of sickle cell disease. Blood samples will be drawn from participants at the Baseline Visit and will be stored until analyzed. Analysis will include learning more about the genetics behind complications of sickle cell disease.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anemia, Sickle Cell</condition>
  <arm_group>
    <arm_group_label>Biorepository substudy participants</arm_group_label>
    <description>Participants from the main study who give consent for the genetic testing substudy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Three tubes of blood (28.5 mL in total) will be obtained at the Baseline Visit. The sample will be stored for future research.</description>
    <arm_group_label>Biorepository substudy participants</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood will be collected, from participants who consent to the optional storage and future
      genetic testing of the sample provided.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The biorepository will consist of research participants from the main study who consent to
        having extra blood drawn and stored for the purpose of future genetic testing.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 15.00 - 40.99 years

          -  Severe sickle cell disease [Hemoglobin SS (Hb SS), Hemoglobin SC (Hb SC) or Hemoglobin
             SBeta thalassemia (Hb Sβ) genotype] with at least 1 of the following manifestations:

               1. Clinically significant neurologic event (stroke) or any neurological deficit
                  lasting &gt; 24 hours;

               2. History of two or more episodes of acute chest syndrome (ACS) in the 2-year
                  period preceding enrollment despite the institution of supportive care measures
                  (i.e. asthma therapy);

               3. Three or more pain crises per year in the 2-year period preceding referral
                  (required intravenous pain management in the outpatient or inpatient hospital
                  setting);

               4. Administration of regular red blood cell (RBC) transfusion therapy, defined as
                  receiving 8 or more transfusions per year for ≥ 1 year to prevent vaso-occlusive
                  clinical complications (i.e. pain, stroke, and acute chest syndrome);

               5. An echocardiographic finding of tricuspid valve regurgitant jet (TRJ) velocity ≥
                  2.7 m/sec.

          -  Adequate physical function as measured by all of the following:

               1. Karnofsky/Lansky performance score &gt; or equal to 60

               2. Cardiac function: Left ventricular ejection fraction (LVEF) &gt; 40%; or LV
                  shortening fraction &gt; 26% by cardiac echocardiogram or by Multi Gated Acquisition
                  (MUGA) Scan

               3. Pulmonary function: Pulse oximetry with a baseline O2 saturation of ≥ 85% and
                  diffusing capacity of the lung for carbon monoxide (DLCO) &gt; 40% (corrected for
                  hemoglobin)

               4. Renal function: Serum creatinine ≤ 1.5 x the upper limit of normal for age as per
                  local laboratory and 24 hour urine creatinine clearance &gt;70 mL/min; or GFR &gt; 70
                  mL/min/1.73 m2 by radionuclide Glomerular Filtration Rate (GFR)

               5. Hepatic function: Serum conjugated (direct) bilirubin &lt; 2x upper limit of normal
                  for age as per local laboratory; alanine aminotransferase (ALT) and aspartate
                  aminotransferase (AST) &lt; 5 times upper limit of normal as per local laboratory.
                  Patients with hyperbilirubinemia as a consequence of hyperhemolysis, or who
                  experience a sudden, profound change in the serum hemoglobin after a RBC
                  transfusion are not excluded.

        Exclusion Criteria:

          -  Human Leukocyte Antigen (HLA) typing prior to referral (consultation with
             hematopoietic cell transplantation (HCT) physician). However, if a subject has had HLA
             typing with accompanying documentation that relatives were not HLA typed and that a
             search of the unrelated donor registry was not performed the subject will be
             considered eligible. Documentation will be reviewed and adjudicated by the Protocol
             Officer or his/her designee.

          -  Uncontrolled bacterial, viral or fungal infection in the 6 weeks before enrollment.

          -  Seropositivity for HIV.

          -  Previous HCT.

          -  Participation in a clinical trial in which the patient received an investigational
             drug or device must be discontinued at enrollment.

          -  A history of substance abuse as defined by version IV of the Diagnostic &amp; Statistical
             Manual of Mental Disorders (DSM IV).

          -  Demonstrated lack of compliance with prior medical care (determined by referring
             physician).

          -  Pregnant or breast feeding females.

          -  Inability to receive HCT due to alloimmunization, defined as the inability to receive
             packed red blood cell (pRBC) transfusion therapy.

          -  Unwillingness to use approved contraception method from time of biologic assignment
             until discontinuation of all immunosuppressive medications if assignment at biologic
             assignment would be to donor arm.

        Additional Eligibility Criteria for Transplant after Biologic Assignment to the Donor Arm:

        Participants assigned to the Donor Arm at the time of biologic assignment are subject to
        additional transplant eligibility criteria as specified below. Additional, repeat clinical
        assessments prior to transplant should be obtained in accordance with institutional
        policies and standards of care in the interest of good clinical practice.

          -  Participants who are receiving ≥8 packed red blood cell transfusions for ≥1 year or
             have received ≥20 packed red blood cell transfusions (cumulative) will undergo liver
             magnetic resonance imaging (MRI) for estimation of hepatic iron content. Liver biopsy
             is indicated for hepatic iron content ≥7 mg Fe/gm liver dry weight. Histological
             examination must document the absence of cirrhosis, bridging fibrosis and active
             hepatitis. The absence of bridging fibrosis will be determined using the histological
             grading and staging scale as described by Ishak and colleagues (1995) as described in
             the Manual of Operating Procedures.

          -  Cerebral MRI/magnetic resonance angiogram (MRA) within 30 days prior to initiation of
             transplant conditioning. If there is clinical or radiologic evidence of a recent
             neurologic event (such as stroke or transient ischemic attack) subjects will be
             deferred for at least 6 months with repeat cerebral MRI/MRA to ensure stabilization of
             the neurologic event prior to proceeding to transplantation.

          -  Absence of donor specific HLA antibodies

          -  Documentation of participant's willingness to use approved contraception method until
             discontinuation of all immunosuppressive medications. This is to be documented in the
             medical record corresponding with the consent conference.

          -  The HLA-matched donor must be medically fit to donate and willing to donate bone
             marrow.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lakshmanan Krishnamurti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lakshmanan Krishnamurti, MD</last_name>
    <phone>404-785-1112</phone>
    <email>lakshmanan.krishnamurti@emory.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chanta Whitlow</last_name>
    <phone>4047850696</phone>
    <email>chanta.whitlow@choa.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Benioff Children's Hospital at Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Walters</last_name>
      <email>MWalters@mail.cho.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allistair Abraham</last_name>
      <email>AAbraham@childrensnational.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Gainsville</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Castillo</last_name>
      <email>castillopa@ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foundation for Sickle Cell Research/Florida Sickle Inc.</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gershwin Blyden</last_name>
      <email>GBlyden@fscdr.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lazaros Lekakis</last_name>
      <email>LLekakis@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grady Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuad El Rassi</last_name>
      <email>fuad.elrassi@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lakshmanan Krishnamurti, MD</last_name>
      <phone>404-785-1441</phone>
      <email>lakshmanan.krishnamurti@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edmund Waller</last_name>
      <email>ewaller@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augusta University Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Pantin</last_name>
      <email>JPANTIN@gru.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Cunningham</last_name>
      <email>jcunning@peds.bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arunkumar Modi</last_name>
      <email>Arunkumar-modi@uiowa.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lolie Yu</last_name>
      <email>lyu@lsuhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oschner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Dalovisio</last_name>
      <email>andrew.dalovisio@ochsner.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute/Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachariah Defilipp</last_name>
      <email>zdefilipp@mgh.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Klings</last_name>
      <email>klingon@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute/Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Antin</last_name>
      <email>jantin@partners.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg Yanik</last_name>
      <email>gyanik@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barbara Ann Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Swerdlow</last_name>
      <email>swerdlow@karmanos.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University/St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Schroeder</last_name>
      <email>markschroeder@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Krajewski</last_name>
      <email>JKrajewski@HackensackUMC.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice J Cohen</last_name>
      <email>acohen@barnabashealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center/Albert Einstein School of Medicine</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murali Janakiram</last_name>
      <email>mjanakir06@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Brooklyn Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayanna Baptiste</last_name>
      <email>amb9075@nyp.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cohen Children's Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Indira Sahdev</last_name>
      <email>ISahdev@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Levine</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsiporah Shore</last_name>
      <email>Tbs2001@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospital at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27516</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Kasow</last_name>
      <email>kimberly_kasow@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Sullivan</last_name>
      <email>keith.sullivan@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Devine</last_name>
      <email>steven.devine@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Selby</last_name>
      <email>George-Selby@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Trisha Wong</last_name>
      <email>wong@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Olsen</last_name>
      <email>olsont@email.chop.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Carella</last_name>
      <email>beth.carella@chp.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Jaroscak</last_name>
      <email>jaroscak@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Sciences Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harinder Juneja</last_name>
      <email>harinder.s.juneja@uth.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine/The Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Premal Lulla</last_name>
      <email>lulla@bcm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas/MD Anderson CRC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uday Popat</last_name>
      <email>upopat@mdanderson.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamila Kindwall-Keller</last_name>
      <email>TLK5DE@hscmail.mcc.virginia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Wiedl</last_name>
      <email>cwiedl@vcu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2016</study_first_submitted>
  <study_first_submitted_qc>July 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2016</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Lakshmanan Krishnamurti</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Biorepository</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

